Vancouver-based healthcare startup Molecular You has secured a $5-million USD ($6.9-million CAD) Series A round following the nationwide launch of its direct-to-consumer blood testing platform in the United States (US).

The round was led by Voloridge Health , the health-focused subsidiary of Florida-based investment management firm Voloridge. Dynamic Leap and other undisclosed investors also participated in the round.

Molecular You is planning the “near-term introduction” of its next-generation test that will measure over 800 biomarkers.

Molecular You was founded in 2014 and claims its predictive health platform can identify health risks and provide a snapshot of full-body health by measuring more than 250 biomarkers in a single blood sample. After a customer has a blood sample drawn in

See Full Page